Allspring Global Investments
ABBV icon

Allspring Global Investments’s AbbVie ABBV Stock Holding History

Allspring Global Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$116M Buy
461,450
+19,803
+4% +$4.26M 0.18% 125
2026
Q1 		$94.9M Buy
441,647
+2,169
+0.5% +$481K 0.16% 150
2025
Q4 		$101M Sell
439,478
-171,116
-28% -$39M 0.16% 154
2025
Q3 		$149M Buy
610,594
+93,560
+18% +$19.1M 0.24% 107
2025
Q2 		$98.2M Sell
517,034
-113,867
-18% -$21.2M 0.16% 153
2025
Q1 		$130M Sell
630,901
-5,803
-0.9% -$1.13M 0.23% 110
2024
Q4 		$114M Buy
636,704
+182,962
+40% +$33.6M 0.18% 128
2024
Q3 		$89.6M Sell
453,742
-65,802
-13% -$12.3M 0.14% 174
2024
Q2 		$89.1M Buy
519,544
+8,679
+2% +$1.44M 0.15% 166
2024
Q1 		$93M Buy
510,865
+5,567
+1% +$959K 0.15% 165
2023
Q4 		$78.3M Buy
505,298
+108,484
+27% +$15.8M 0.13% 192
2023
Q3 		$59.1M Buy
396,814
+19,814
+5% +$2.91M 0.11% 246
2023
Q2 		$50.8M Sell
377,000
-233,365
-38% -$34.2M 0.08% 318
2023
Q1 		$97.3M Sell
610,365
-150,223
-20% -$23M 0.16% 149
2022
Q4 		$123M Sell
760,588
-341,456
-31% -$52.4M 0.21% 117
2022
Q3 		$148M Sell
1,102,044
-236,261
-18% -$33.9M 0.26% 77
2022
Q2 		$205M Sell
1,338,305
-394,641
-23% -$60.3M 0.34% 53
2022
Q1 		$281M Sell
1,732,946
-282,335
-14% -$41M 0.35% 45
2021
Q4 		$273M Buy
+2,015,281
New +$238M 0.3% 60

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Allspring Global Investments's ABBV Position: Q2 2026 in Review

Allspring Global Investments increased its AbbVie (ABBV) stake by 4.5% in Q2 2026, buying an estimated $4.26M and bringing the position to 461,450 shares worth $116M. The position accounts for 0.18% of the portfolio, ranked #125.

Allspring Global Investments first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $281M in Q1 2022. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Allspring Global Investments held 461,450 shares of AbbVie worth $116M as of Q2 2026.
  • Allspring Global Investments bought 19,803 AbbVie shares in Q2 2026, an estimated $4.26M.
  • AbbVie made up 0.18% of Allspring Global Investments's portfolio in Q2 2026, its #125 holding.
  • Allspring Global Investments first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's AbbVie position peaked at $281M in Q1 2022.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.